Federal contract award

75N93020F00003

THE CONTRACTOR SHALL PERFORM ASSAY DEVELOPMENT AND VALIDATION TO IDENTIFY AND EVALUATE EFFICACY OF ANTI-HIV THERAPEUTICS AND TOPICAL MICROBICIDES. NOTE: THE VALIDATION PROCESS INCLUDES THE DETERMINATION AND OPTIMIZATION OF THE ACCURACY, PRECISION, RE

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541712
PSCAN81 — AIDS RESEARCH - BASIC RESEARCH
Parent award / vehicleHHSN272201400010I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$214.1K
Current contract value$214.1K
Potential contract value / ceiling$214.1K
Start dateAug 1, 2020
Current end dateJul 31, 2022
Potential end dateJul 31, 2022
Latest award activityMay 5, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 5, 2025P00003$-86.0KIN VITRO TESTING RESOURCE FOR HIV THERAPEUTICS AND TOPICAL MICROBICIDES-DEOBLIGATE FUNDS FROM LINE ITEM 1

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.